Novavax Gains Competitive Edge with FDA Clearance and Strategic Collaborations, Earning Buy Rating
H.C. Wainwright analyst Vernon Bernardino reiterated a Buy rating on Novavax (NVAX – Research Report) today and set a price target of ...
Live Science on MSN18d
Older adults should get 2 doses of the updated COVID shot, CDC says
Adults 65 and older and people with weakened immune systems should get two doses of the newly updated COVID-19 vaccine, the ...
Hosted on MSN14d
Some Americans need more than one COVID booster this season, CDC says. What to know
There is an exception for those choosing to receive a Novavax vaccine, according to the CDC. If you are getting a shot for the first time, you need two Novavax vaccines to be considered “up to ...
US FDA lifts clinical hold on Novavax's combo COVID-flu shot
The U.S. Food and Drug Administration has lifted its clinical hold on a late-stage trial of Novavax's COVID-influenza and its standalone flu vaccines, the company said on Monday.
Adults 50 and older should now get this vaccine, according to the CDC
The vaccine helps to prevent bacterial infections that can cause serious illness in older adults, such as pneumonia.
Yahoo Finance12d
Here is What to Know Beyond Why Novavax, Inc. (NVAX) is a Trending Stock
Novavax (NVAX) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.
devdiscourse20h
Healthcare Headlines: Legal Battles, Financial Shifts, and Market Trends
This article summarizes key developments in the health sector including a lawsuit blocking UnitedHealth's purchase of ...